These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20831903)

  • 1. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.
    Yang JD; Kim WR; Coelho R; Mettler TA; Benson JT; Sanderson SO; Therneau TM; Kim B; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jan; 9(1):64-70. PubMed ID: 20831903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
    Aljumah AA; Kuriry H; Faisal N; Alghamdi H
    Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.
    Roayaie S; Haim MB; Emre S; Fishbein TM; Sheiner PA; Miller CM; Schwartz ME
    Ann Surg Oncol; 2000 Dec; 7(10):764-70. PubMed ID: 11129425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence.
    Mohamed EA; Giama NH; Abdalla AO; Shaleh HM; Oseini AM; Ali HA; Ahmed F; Taha W; Ahmed Mohammed H; Cvinar J; Waaeys IA; Ali H; Allotey LK; Ali AO; Mohamed SA; Harmsen WS; Ahmmad EM; Bajwa NA; Afgarshe MD; Shire AM; Balls-Berry JE; Roberts LR
    World J Gastroenterol; 2022 Sep; 28(35):5217-5229. PubMed ID: 36188718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance.
    Schauer C; Mules T; Rijnsoever MV; Gane E
    N Z Med J; 2020 May; 133(1515):25-34. PubMed ID: 32438374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic viral hepatitis and hepatocellular carcinoma.
    Barazani Y; Hiatt JR; Tong MJ; Busuttil RW
    World J Surg; 2007 Jun; 31(6):1243-8. PubMed ID: 17440771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of hepatitis B and C virus-associated hepatocellular carcinoma occurring after renal transplantation.
    Kanaan N; Raggi C; Goffin E; De Meyer M; Mourad M; Jadoul M; Beguin C; Kabamba B; Borbath I; Pirson Y; Hassoun Z
    J Viral Hepat; 2017 May; 24(5):430-435. PubMed ID: 27917563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth.
    Zampino R; Marrone A; Merola A; Trani B; Cirillo G; Karayiannis P; Coppola N; Zappalà R; Utili R; Ruggiero G; Adinolfi LE
    J Med Virol; 2009 Dec; 81(12):2012-20. PubMed ID: 19856471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma.
    Shire AM; Sandhu DS; Kaiya JK; Oseini AM; Yang JD; Chaiteerakij R; Mettler TA; Giama NH; Roberts RO; Therneau TM; Petersen GM; Knutson KL; Roberts LR
    Mayo Clin Proc; 2012 Jan; 87(1):17-24. PubMed ID: 22212964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of chronic hepatitis B and C.
    Imperial JC
    J Gastroenterol Hepatol; 1999 May; 14 Suppl():S1-5. PubMed ID: 10382630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.
    Zampino R; Pisaturo MA; Cirillo G; Marrone A; Macera M; Rinaldi L; Stanzione M; Durante-Mangoni E; Gentile I; Sagnelli E; Signoriello G; Miraglia Del Giudice E; Adinolfi LE; Coppola N
    Ann Hepatol; 2015; 14(1):75-82. PubMed ID: 25536644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations.
    Raptis I; Koskinas J; Emmanouil T; Hadziyannis S
    J Viral Hepat; 2003 Nov; 10(6):450-4. PubMed ID: 14633179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
    Lok AS
    J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
    Sun S; Li Y; Han S; Jia H; Li X; Li X
    BMC Med Genomics; 2019 Oct; 12(1):147. PubMed ID: 31660973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.